1st Quarter 2018
Key topics in this quarter’s edition include:
- Erenumab - prevention of migraine headaches in adult patients experiencing ≥ 4 migraines per month
- Fremanezumab - prevention of migraine headaches in adult patients
- Cannabidiol - adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Top